Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential
- 31 July 1993
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 14 (7), 265-270
- https://doi.org/10.1016/0165-6147(93)90128-7
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic propertiesEuropean Journal of Pharmacology, 1993
- Cisplatin-induced conditioned taste aversion: attenuation by dexamethasone but not zacopride or GR38032FEuropean Journal of Pharmacology, 1992
- Anxiolytic Potential of 5‐HT3 Receptor AntagonistsBasic & Clinical Pharmacology & Toxicology, 1992
- Recent advances in the electrophysiological characterization of 5-HT3 receptorsTrends in Pharmacological Sciences, 1992
- The peripheral nociceptive actions of intravenously administered 5-HT in the rat requires dual activation of both 5-HT2 and 5-HT3 receptor subtypesBrain Research, 1991
- Spinal 5-HT3 receptor-mediated antinociception: possible release of GABAJournal of Neuroscience, 1991
- Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonistsPsychopharmacology, 1990
- 5-HT3 receptors modulate spinal nociceptive reflexesBrain Research, 1990
- Effects of serotonin receptor antagonists on PAG stimulation induced aversion: different contributions of 5HT1, 5HT2 and 5HT3 receptorsPsychopharmacology, 1989
- Similar effects of diazepam and the 5-HT3 receptor antagonist ICS 205-930 on place aversion conditioningEuropean Journal of Pharmacology, 1988